Browsing Centre for Immunobiology by Author "Tadolini, M"
Now showing items 1-8 of 8
-
Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study.
Migliori, GB; Thong, PM; Alffenaar, J-W; Denholm, J; Tadolini, M; Alyaquobi, F; Al-Abri, S; Blanc, F-X; Buonsenso, D; Chakaya, J (2022)The objective of this study was to describe country-specific lockdown measures and tuberculosis indicators collected during the first year of the COVID-19 pandemic. Data on lockdown/social restrictions (compulsory face ... -
COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom
Garcia-Garcia, J-M; Blanc, F-X; Buonsenso, D; Centis, R; Codecasa, LR; D'Ambrosio, L; Goletti, D; Gualano, G; Kunst, H; Pontali, E (2022) -
Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis
Sotgiu, G; Tiberi, S; D'Ambrosio, L; Centis, R; Alffenaar, JW; Caminero, JA; Arbex, MA; Guizado, VA; Alekasa, A; Dore, S (European Respiratory Society, 2016-10-31) -
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.
Koirala, S; Borisov, S; Danila, E; Mariandyshev, A; Shrestha, B; Lukhele, N; Dalcolmo, M; Shakya, SR; Miliauskas, S; Kuksa, L (2021-03-19)The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively evaluate the effectiveness of bedaquiline ... -
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
van den Elsen, SHJ; Sturkenboom, MGG; Akkerman, O; Barkane, L; Bruchfeld, J; Eather, G; Heysell, SK; Hurevich, H; Kuksa, L; Kunst, H (2020) -
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
Akkerman, O; Aleksa, A; Alffenaar, J-W; Al-Marzouqi, NH; Arias-Guillen, M; Belilovski, E; Bernal, E; Boeree, MJ; Borisov, SE; Bruchfeld, J (2019-06) -
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
Borisov, S; Danila, E; Maryandyshev, A; Dalcolmo, M; Miliauskas, S; Kuksa, L; Manga, S; Skrahina, A; Diktanas, S; Codecasa, LR (European Respiratory Society, 2019-12-19)WHO (World Health Organization) recommends countries to implement pharmacovigilance and to collect information on aDSM (active drug safety monitoring and management of adverse events-AEs). Aim of this prospective study ... -
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020
Migliori, GB; Thong, PM; Akkerman, O; Alffenaar, J-W; Alvarez-Navascues, F; Assao-Neino, MM; Bernard, PV; Biala, JS; Blanc, F-X; Bogorodskaya, EM (2020-09-11)